Jump To
The Future of Healthtech 2026
Key takeaways
Healthtech is everywhere—and in 2026, it's being put to the test. Capital is still flowing, but investors want proof that products improve outcomes or lower costs. This healthtech report draws on our proprietary research to reveal where healthtech and digital health funding is moving and what AI is really worth.
64%
Valuation premium for early-stage AI healthtech companies over non-AI peers
Late-stage AI companies experience a 52% valuation premium.
$74M
Median pre-money valuations among late-stage companies
Late-stage valuations climbed 63% this year as investors focus on mature companies with proven effectiveness.
47%
Of 2026 healthtech funding went to $100M+ rounds
Only 3% of deals drove nearly half of funding, with giga-rounds hitting the highest share ever (12%).
Behind the data
The numbers behind the takeaways tell a deeper story. Here’s what the data reveals about healthtech investment, the climb in late-stage deal sizes and the return of giga-rounds.
Value-based care valuations and VC reach new heights
Investment in clinical value-based care is projected to reach $2.3 billion in 2026—the most since 2021—with median valuations spiking to $100 million.
Investors are pouring capital into companies that can demonstrate outcomes and savings in a matter of months, rewarding proven effectiveness over promise.
Early- and late-stage healthtech valuations hit new highs
Median early-stage pre-money valuations have risen 130% to $46 million since 2020, the largest jump across stages.
Seed valuations have nearly doubled since 2020, yet seed deals reflect a quarter of all deals and 5% of capital, a gap that underscores how funding concentrates around maturity and traction.
The giga-round is back and bigger than ever
Rounds of $500 million or more accounted for 12% of healthtech venture capital this year, the highest ratio on record, after 2 years with none at all.
Neko Health, WHOOP and Alan led the giga-round comeback, as investors directed record capital into a small group of established winners.
Read the full Future of Healthtech report
Explore other reports
Reports
Healthcare Industry Trends
Megan Scheffel, Adam Tweedy, Dennis He, Matt Donne, Alex Lennox-Miller, Josh Pherigo, Urbashee Paul
Reports
Innovation in Women's Health
Megan Scheffel, Adam Tweedy, Nina Kandilian, Alex Lennox-Miller, Josh Pherigo, Urbashee Paul
Reports
State of the VC-Backed CFO 2026
Jennifer Friel Goldstein, Emily Gonsenheim, Josh Pherigo, Eli Oftedal, Andrew Pardo